Seven Bridges Genomics Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
367
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
13
- Investments
-
1
Seven Bridges Genomics General Information
Description
Developer of a biomedical data analysis platform designed to accelerate scientific discovery. The company's platform delivers end-to-end bioinformatic data analytics including access to datasets, analytic workflows and algorithms, cloud-computing infrastructure and scientific support that speeds the path from raw experimental data to new treatments and diagnostics, enabling companies to accelerate scientific discovery with secure and collaborative genomic and healthcare data analytics.
Contact Information
Website
www.sevenbridges.comCorporate Office
- Schrafft's City Center, 529 Main Street
- Suite 6610, Charlestown
- Boston, MA 02129
- United States
Corporate Office
- Schrafft's City Center, 529 Main Street
- Suite 6610, Charlestown
- Boston, MA 02129
- United States
Seven Bridges Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Seven Bridges Genomics Comparisons
Industry
Financing
Details
Seven Bridges Genomics Competitors (2)
One of Seven Bridges Genomics’s 2 competitors is DNAnexus, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DNAnexus | Venture Capital-Backed | San Francisco, CA | ||||
| Genuity Science | Formerly VC-backed | Dublin, Ireland |
Seven Bridges Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Seven Bridges Genomics Patents
Seven Bridges Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250253011-A1 | Techniques for improved tumor mutational burden (tmb) determination using a population-specific genomic reference | Pending | 02-Feb-2024 | ||
| WO-2025165590-A1 | Techniques for improved tumor mutational burden (tmb) determination using a population-specific genomic reference | Pending | 02-Feb-2024 | ||
| WO-2025165590-A8 | Techniques for improved tumor mutational burden (tmb) determination using a population-specific genomic reference | Pending | 02-Feb-2024 | ||
| EP-4805943-A1 | Techniques for detecting de novo and rare variants using a family graph reference | Pending | 08-Nov-2023 | ||
| US-20250149117-A1 | Techniques for detecting de novo and rare variants using a family graph reference | Pending | 08-Nov-2023 | G16B30/10 |
Seven Bridges Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Seven Bridges Genomics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Seven Bridges Genomics Investments (1)
Seven Bridges Genomics’s most recent deal was a Corporate with Spatial Transcriptomics. The deal was made on 04-Apr-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Spatial Transcriptomics | 04-Apr-2017 | Corporate | Biotechnology |
Seven Bridges Genomics Exits (1)
Seven Bridges Genomics’s most recent exit was on 04-Apr-2017 from Spatial Transcriptomics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Spatial Transcriptomics | 04-Apr-2017 | Completed |
|
Seven Bridges Genomics FAQs
-
When was Seven Bridges Genomics founded?
Seven Bridges Genomics was founded in 2009.
-
Where is Seven Bridges Genomics headquartered?
Seven Bridges Genomics is headquartered in Boston, MA.
-
What is the size of Seven Bridges Genomics?
Seven Bridges Genomics has 367 total employees.
-
What industry is Seven Bridges Genomics in?
Seven Bridges Genomics’s primary industry is Enterprise Systems (Healthcare).
-
Is Seven Bridges Genomics a private or public company?
Seven Bridges Genomics is a Private company.
-
What is Seven Bridges Genomics’s current revenue?
The current revenue for Seven Bridges Genomics is .
-
How much funding has Seven Bridges Genomics raised over time?
Seven Bridges Genomics has raised $113M.
-
Who are Seven Bridges Genomics’s investors?
First Star Ventures and Kryssen Capital have invested in Seven Bridges Genomics.
-
Who are Seven Bridges Genomics’s competitors?
DNAnexus and Genuity Science are competitors of Seven Bridges Genomics.
-
When was Seven Bridges Genomics acquired?
Seven Bridges Genomics was acquired on 07-Jun-2022.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
